Atea Pharmaceuticals logo
Atea Pharmaceuticals AVIR
€ 5.08 -0.26%

Geschäftsbericht 2025
hinzugefügt 05.03.2026

report update icon

Atea Pharmaceuticals Langfristiger Schuldenstrom 2011-2026 | AVIR

Langfristiger Schuldenstrom Jährlich Atea Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
843 K 800 K 760 K 721 K 197 K - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
843 K 197 K 664 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.34 -3.6 % $ 357 M britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.65 1.3 % $ 8.78 B australiaAustralia
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.57 -3.38 % $ 16.1 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
BioNTech SE BioNTech SE
BNTX
45 M $ 87.73 -3.89 % $ 27.2 B germanyGermany
Coherus BioSciences Coherus BioSciences
CHRS
1.83 M $ 1.6 -4.19 % $ 187 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
45.5 M $ 315.02 -4.64 % $ 41.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
argenx SE argenx SE
ARGX
10.8 M $ 750.73 0.33 % $ 25 B niderlandNiderland
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.88 -0.59 % $ 4.8 M chinaChina
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Cerus Corporation Cerus Corporation
CERS
2.9 M $ 1.84 -0.81 % $ 351 M usaUSA
AbbVie AbbVie
ABBV
194 M $ 202.18 -2.15 % $ 358 B usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.01 -2.08 % $ 429 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 3.24 -4.57 % $ 968 M canadaCanada
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
4.21 M $ 8.17 -0.61 % $ 224 M israelIsrael